VIA
NRX

Vantage Investment Advisors’s NEPHROGENEX INC COM NRX Stock Holding History

Vantage Investment Advisors’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,700
Closed – – 887
2016
Q3 		$0 Hold
3,700
– – ﹤0.01% 891
2016
Q2 		$0 Hold
3,700
– – ﹤0.01% 934
2016
Q1 		$2K Hold
3,700
– – ﹤0.01% 734
2015
Q4 		$6K Hold
3,700
– – ﹤0.01% 599
2015
Q3 		$13K Buy
+3,700
New +$16.2K 0.01% 453

Vantage Investment Advisors's NRX Position: Q4 2016 in Review

Vantage Investment Advisors sold out of NEPHROGENEX INC COM (NRX) in Q4 2016, closing a stake of 3,700 shares.

Vantage Investment Advisors first reported a position in NRX in Q3 2015 and held it in 5 quarters. The position peaked at $13K in Q3 2015. 0 funds tracked by Wall St. Rank hold NRX as of Q4 2016.

  • Vantage Investment Advisors reported no remaining NEPHROGENEX INC COM position as of Q4 2016 after selling out during the quarter.
  • Vantage Investment Advisors sold 3,700 NEPHROGENEX INC COM shares in Q4 2016.
  • Vantage Investment Advisors first reported a position in NEPHROGENEX INC COM in Q3 2015 and held it in 5 quarters.
  • Vantage Investment Advisors's NEPHROGENEX INC COM position peaked at $13K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q4 2016.

Based on Vantage Investment Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.